Medicare Boosts Payment Rates For Pricey New Treatments, But Health Providers Disappointed It’s Not More

“Under this plan, I have concern that access to CAR T won’t be universal,” said Jayson Slotnik, a partner at Health Policy Strategies. Some argue Medicare should pay for 80 to 100 percent of the pricey cancer treatment. In other Medicare news, CMS finalizes a long-requested wage index boost.

from Kaiser Health News https://ift.tt/2KrzUDs